Intimation under regulation 30 of SEBI (LODR), 2025 for reappointment of Mrs. Rachna Ghai as an Woman Independent Director for the second term of 5 years.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem Ltd has reappointed Mrs. Rachna Manav Ghai (DIN: 08885422) as a Woman Independent Director (Non-Executive) for a second consecutive term of five years, from 14th September 2025 to 13th September 2030. The reappointment was approved by the Board on 1st August 2025, based on the recommendation of the Nomination and Remuneration Committee, and is subject to shareholder approval at the next general meeting. Mrs. Ghai holds a BSc and a PGDBM, with experience in education and general administration, and is not related to any existing Director, KMP, or Promoter of the company. The company confirmed she meets the independence criteria under the Companies Act, 2013 and SEBI LODR Regulations.
This is a routine governance disclosure with no material impact on shareholders or stock price. It signals board continuity and compliance with SEBI norms regarding woman independent directors on the board.